Monoclonal antibody therapy of T cell lymphoma: Single agent trials of anti-CD2 (Siplizumab) and anti-CD4 (Humax-CD4)

John Edward Janik, D. O'Mahony, T. A. Waldmann, J. C. Morris

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Monoclonal antibody therapy of T cell lymphoma: Single agent trials of anti-CD2 (Siplizumab) and anti-CD4 (Humax-CD4)'. Together they form a unique fingerprint.